Rating History for Ascendis Pharma (ASND) by BMO Capital

More Stocks Rated by BMO Capital | Latest Ratings for ASND
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/18/2026 David Lebowitz New Coverage Outperform
(N/A)		 39.00
(N/A)		 247.40
(260.25)		 5.19% Details